Stem-cell factor regulates the expression of cyclin A and retinoblastoma gene product in the growth and differentiation pathway of human megakaryocytic cells

[1]  D. Metcalf.  THROMBOPOIETIN : AT LAST , 1994 .

[2]  D. Morton,et al.  Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cells. , 1994, Cancer research.

[3]  Y. Kishimoto,et al.  Expression of platelet alpha-granule proteins in a human megakaryocytic leukemia cell line (CMK 11-5). , 1993, International journal of hematology.

[4]  K. Oshimi,et al.  Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. , 1993, Blood.

[5]  S. Reed,et al.  Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. , 1992, Genes & development.

[6]  K. Matsumoto,et al.  Phosphorylation of the retinoblastoma protein by cdk2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Y. Akiyama,et al.  Tumor Necrosis Factor‐a Stimulates Colony Formation by a Megakaryoblastic Leukemia Cell Line, CMK , 1992, Japanese journal of cancer research : Gann.

[8]  S. Burstein,et al.  Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6 , 1992 .

[9]  C. Willman,et al.  False-positive flow cytometric platelet glycoprotein IIb/IIIa expression in myeloid leukemias secondary to platelet adherence to blasts. , 1992, Blood.

[10]  E. Harlow,et al.  The retinoblastoma protein physically associates with the human cdc2 kinase , 1992, Molecular and cellular biology.

[11]  H. Ito,et al.  Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling. , 1992, Cancer research.

[12]  J. Nevins,et al.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex , 1992, Cell.

[13]  M. Adachi,et al.  Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK11-5). , 1991, Experimental hematology.

[14]  Richard A. Ashmun,et al.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.

[15]  B. Futcher,et al.  Human D-type cyclin , 1991, Cell.

[16]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[17]  W. Lee,et al.  Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. , 1991, The EMBO journal.

[18]  J. Van Damme,et al.  Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK , 1991, British journal of haematology.

[19]  P. Leder,et al.  The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus , 1990, Cell.

[20]  F. Kaye,et al.  A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Tony Hunter,et al.  Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B , 1990, Nature.

[22]  J. Massagué,et al.  Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.

[23]  C. Williams,et al.  A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. , 1990, British Journal of Cancer.

[24]  Phang-lang Chen,et al.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.

[25]  E. Harlow,et al.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.

[26]  David M. Livingston,et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.

[27]  T. Suda,et al.  Growth and differentiation of a human megakaryoblastic cell line, CMK. , 1989, Blood.

[28]  Y. Hayashi,et al.  Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia , 1989, British journal of haematology.

[29]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[30]  K. Oshimi,et al.  Clonal growth of human megakaryocyte progenitors in serum-free cultures: effect of recombinant human interleukin 3. , 1988, Experimental hematology.

[31]  C. Ware,et al.  Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. , 1984, Journal of immunological methods.

[32]  N. Keiding,et al.  Long-term storage of samples for flow cytometric DNA analysis. , 1983, Cytometry.

[33]  小林 祥子.  Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines , 1994 .

[34]  S. Jiang,et al.  Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. , 1992, Blood.

[35]  S. Burstein,et al.  Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6. , 1992, Blood.

[36]  A. Kimchi,et al.  Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Kawakita,et al.  Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. , 1992, Experimental hematology.

[38]  A. Yen,et al.  Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. , 1989, Science.